Live Q&A: Real-world Tactics to Address Health Inequities in Prostate Cancer Care
CMEO Webcast
Premiere Date: Tuesday, November 29, 2022This activity offers CE credit for:
- Medicine (accme)
- Nursing (ANCC)
- Pharmacy (acpe)
- PA (aapa)
- Other
All other clinicians will receive a Certificate of Attendance stating this activity was certified for AMA PRA Category 1 Credit™
Credit Expiration Date: Wednesday, November 29, 2023
%>
Begin Activity
Faculty
![]() |
Edith Peterson Mitchell, MD, MACP, FCPP, FRCP (Moderator) Clinical Professor of Medicine and Medical Oncology Department of Medical Oncology Director, Center to Eliminate Cancer Disparities Associate Director, Diversity Affairs Sidney Kimmel Cancer Center at Jefferson Philadelphia, PA 116th President of the National Medical Association |
![]() |
Quoc-Dien Trinh, MD Associate Professor of Surgery Harvard Medical School Director, Ambulatory Clinical Operations Division of Urological Surgery Co-Director, Dana-Farber/Brigham and Women's Prostate Cancer Program Boston, MA |
Statement of Need
Racial and ethnic disparities in prostate cancer are well documented. Compared with White males, Black males have a 1.5 times higher chance of developing prostate cancer and 2.2 times higher likelihood of death resulting from the disease. Gaps in early diagnosis, treatment options and access, survival rate, and more remain for racial and ethnic underserved populations. A culmination of biases, disparities, and inequities continues a cycle of inadequate oncological treatment for prostate cancer, thus resulting in delayed diagnosis and suboptimal clinical management, prognosis, and survival rate.
This live Q&A session is your opportunity to ask questions based on the CME Outfitters BriefCase that focused on racial and ethnic disparities and health inequities in prostate cancer.
Learning Objectives
At the end of this CME/CE activity, participants should be able to:
%End>- Recognize the impact of health inequities on patients with prostate cancer and develop individual treatment strategies for optimal clinical outcomes.
Financial Support
Supported by an educational grant from the Johnson & Johnson Institute and the Johnson & Johnson Family of Companies
Target Audience
Physicians, PAs, nurse practitioners, nurses/nurse navigators, pharmacists, specializing in oncology , pathology, anesthesiology, and primary care.
Credit Information
Jointly Accredited Provider
In support of improving patient care, CME Outfitters, LLC, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physicians (ACCME):
CME Outfitters, LLC, designates this live activity for a maximum of 0.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurses (ANCC):
This activity is designated for 0.5 contact hours.
Note to Nurse Practitioners:
Nurse practitioners can apply for AMA PRA Category 1 Credit(s)™ through the American Academy of Nurse Practitioners (AANP). AANP will accept AMA PRA Category 1 Credit(s)™ from Jointly Accredited Organizations. Nurse practitioners can also apply for credit through their state boards.
California Residents:
This continuing nursing education activity was approved by the California Board of Registered Nursing. CME Outfitters LLC’s provider number is CEP15510.
Pharmacists (ACPE):
This application-based activity is approved for 0.5 contact hours (0.05 CEUs) of continuing pharmacy credit (JA0007185-0000-22-135-L01-P).
PAs (AAPA):
CME Outfitters, LLC, has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 0.5 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
Provider approved by the California Board of Registered Nursing, Provider Number CEP 15510, for 0.5 contact hours
It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CE activity. CME Outfitters, LLC, has evaluated, identified, and mitigated any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process. The following information is for participant information only. It is not assumed that these relationships will have a negative impact on the presentations.Dr. Mitchell reports the following financial relationships:
Advisory Board: Corvus Pharmaceuticals, Inc.
Consultant: Amgen Inc.; Astellas Pharma Inc.; Bristol Myers Squibb; Genentech, Inc.; and SEMA4 OpCo, Inc.
Dr. Trinh reports the following financial relationships:
Consultant: Astellas Pharma US, Inc. and Bayer AG
Grants: Pfizer Inc.
The following peer reviewer and CME Outfitters staff have no financial relationships:
Faculty of this CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices.
Post-tests, credit request forms, and activity evaluations must be completed online (requires free account activation), and participants can print their certificate or statement of credit immediately (75% pass rate required). This website supports all browsers except Internet Explorer for Mac. For complete technical requirements and privacy policy, visit https://www.cmeoutfitters.com/privacy-and-confidentiality-policy.
Questions about this activity? Call us at 877.CME.PROS (877.263.7767).
This document was last modified on:
BCQ-069-112922-57